DNA adducts and chronic degenerative diseases. Pathogenetic relevance and implications in preventive medicine

Mutation Research - Reviews in Genetic Toxicology

Volumn 366, Issue 3, 1996, Pages 197-238

  De Flora, Silvio ^a   Izzotti, Alberto ^a   Randerath, Kurt ^b   Randerath, Erika ^b   Bartsch, Helmut ^c   Nair, Jagadeesan ^c   Balansky, Roumen ^d   Van Schooten, Frederikjan ^e   Degan, Paolo ^f   Fronza, Gilberto ^f   Walsh, Debra ^g   Lewtas, Joellen ^g  

^a UNIVERSITY OF GENOA   (Italy)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^d National Oncology Center Bulgaria   (Bulgaria)

^e MAASTRICHT UNIVERSITY   (Netherlands)

^f UNIVERSITY OF GENOA   (Italy)

^g U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

Atherogenesis; Carcinogenesis; Chronic degenerative disease; DNA adduct; Heart disease; Mitochondrial DNA; Nuclear DNA; Prevention

Indexed keywords

CELL NUCLEUS DNA; MITOCHONDRIAL DNA;

ATHEROGENESIS; CARCINOGENESIS; CHRONIC DISEASE; DEGENERATIVE DISEASE; DNA ADDUCT; HEART; HEART DISEASE; HUMAN; LIVER; LUNG; PRIORITY JOURNAL; REVIEW;

EID: 0030604254     PISSN: 01651110     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-1110(96)00043-7     Document Type: Article

References (221)

1. [1] World Health Organization (1992) International Statistical Classification of Diseases and Related Health Problems, Tenth Revision. Vol. 1. World Health Organization, Geneva, Switzerland.
2. [2] U.S. Department of Health and Human Services (1992) Trends in ischemic heart disease mortality-United States, 1980-1988. Morbidity and Mortality Weekly Rep., 41, 548-549 and 555-556.
3. [3] Decarli, A. and C. La Vecchia (1994) Cancer mortality in Italy. Tumori, 80, 405-415.
4. [4] U.S. Department of Health and Human Services (1991) Strategies to control tobacco use in the United States. NIH Publication No. 92-3316.
5. [5] De Flora, S., M. Bagnasco and P. Zanacchi (1992) Classification and mechanism of action of chemopreventive compounds, in: G. De Paolo, M. Sporn and U. Veronesi (Eds), Progress and Perspectives in Chemoprevention of Cancer, Raven Press, New York, pp. 1-11.
6. [6] Tomatis, L., A. Aitio, N.B. Day, E. Heseltine, J. Kaldor, A.B. Miller, D.M. Parkin and E. Riboli (1990) Cancer: Causes, Occurrence and Control. IARC Sci. Publ. No. 100, International Agency for Research on Cancer, Lyon, France.
7. [7] Ames, B.N. (1983) Dietary carcinogens and anticarcinogens. Science, 221, 1256-1263.
8. [8] Kendall, C.W., M. Koo, E. Sokoloff and A.V. Rao (1992) Effect of dietary oxidized cholesterol on azoxymethane-induced colonic preneoplasia in mice. Cancer Lett., 76, 241-248.
9. [9] Tomatis, L. (1995) How much of the human disease burden is attributable to environmental chemicals?. Toxicol. Lett., 77, 1-8.
10. [10] The Inter-Society Commission for Heart Disease Resource Report (1984) Primary prevention of the atherosclerotic diseases. Circulation, 70, 153a-205a.
11. [11] Blackburn, H. and R. Luepker (1986) Heart disease, in: M.J. Last, J. Chin, J.E. Fielding, A.L. Frank, J.C. Lashof and R.B. Wallace (Eds.), Maxcy-Rosenau Public Health and Preventive Medicine, Appleton-Century-Crofts, Norwalk, CT, pp. 1159-1193.
12. [12] Fearon, E.R. and B. Volgstein (1990) A genetic model for colorectal tumorigenesis. Cell, 61, 759-767.
13. [13] Boone, C.W., G.J. Kelloff and V.E. Steele (1992) Natural hystory of intraepithelial neoplasia in humans with implications for cancer chemopreventive strategy. Cancer Res., 52, 1651-1659.
14. [14] Trosko, J. and C. Chang (1980) An integrative hypothesis linking cancer, diabetes, and atherosclerosis: The role of mutations and epigenetic changes. Med. Hypoth., 6, 455-468.
15. [15] Slaughter, D.P., H.W. Southwick and W. Smejkal (1953) 'Field cancerization' in oral stratified squamous epithelium: clinical implications of multicentric origin. Cancer, 6, 963-968.
16. [16] Johnson, R.A. and I. Palacios (1982) Dilated cardiomyopathies of the adult. N. Engl. J. Med., 307, 1051-1058.
17. 32P for DNA damage. Proc. Natl. Acad. Sci. USA, 78, 6126-6129.
18. [18] Garg, A., C.A. Beach and R.C. Gupta (1993) Interception of reactive, DNA adduct-forming metabolites present in rodent serum following carcinogen exposure: implications for use of body fluids in biomonitoring. Teratogen. Carcinogen. Mutagen., 13, 151-166.
19. 32P-Postlabelling analysis of DNA adducted with urinary mutagens from smokers of black tobacco. Carcinogenesis, 11, 1307-1311.
20. 32P postlabeling, in DNA reacted in vitro with bile from patients with familial adenomatous polyposis and from unaffected controls. Carcinogenesis, 14, 1107-1110.
21. [21] Izzotti, A., M. Orlando, C. Di Marco and L. Scatolini (1996) Molecular toxicokinetics and organotropism of polycylic aromatic hydrocarbons (in Italian), in: P. Apostoli, E. Clonfero, C. Raggi and F. Valerio (Eds.), Proceedings 'Convegno Idrocarburi Policiclici Aromatici negli Ambienti di Vita e di Lavoro: Esposizioni ed Effetti', Brescia, Italy, in press.
22. [22] De Flora, S., S. Petruzzelli, A. Camoirano, C. Bennicelli, M. Romano, M. Rindi, L. Ghelarducci and C. Giuntini (1987) Pulmonary metabolism of mutagens and its relationship with lung cancer and smoking habits. Cancer Res., 47, 4740-4745.
23. [23] Bartsch, H., S. Petruzzelli, S. De Flora, E. Hietanen, A.-M. Camus, M. Castegnaro, O. Geneste, A. Camoirano, R. Saracci and C. Giuntini (1991) Carcinogen metabolism and DNA-adducts in human lung tissues as affected by tobacco smoking or metabolic phenotype: a case-control study on lung cancer patients. Mutation Res., 250, 103-114.
24. [24] Stowers, S.J. and M.W. Anderson (1985) Formation and persistence of benzo[a]pyrene metabolite-DNA adducts. Environ. Health Perspect., 62, 31-39.
25. [25] Bagnasco, M., C. Bennicelli, A. Camoirano, R. Balansky and S. De Flora (1992) Metabolic alterations produced by cigarette smoke in rat lung and liver, and their modulation by oral N-acetylcysteine. Mutagenesis, 7, 295-301.
26. [26] Bond, J.A., R.M. Kocan, E.P. Benditt and M.R. Juchau (1979) Metabolism of benzo[a]pyrene and 7,12-dimethyl-benz[a]anthracene in cultured human fetal aortic smooth muscle cells. Life Sci., 25, 425-430.
27. [27] Alexandrov, K., M. Rojas, O. Geneste, M. Castegnaro, A.M. Camus, S. Petruzzelli, C. Giuntini and H. Bartsch (1992) An improved fluorometric assay for dosimetry of benzo[a]pyrene diol-epoxide-DNA adducts in smokers' lung: comparisons with total bulky adducts and AHH activity, Cancer Res., 52, 6248-6253.
28. [28] Izzotti, A., R. Balansky, N. Coscia, L. Scatolini, F. D'Agostini and S. De Flora (1992) Chemoprevention of smoke-related DNA adduct formation in rat lung and heart. Carcinogenesis, 13, 2187-2190.
29. [29] Balansky, R., F. D'Agostini and S. De Flora (1992) Protection by N-acetylcysteine of the histopathological and cytogenetical damage produced by exposure of rats to cigarette smoke. Cancer Lett., 64, 123-131.
30. [30] Idell, S. and A.B. Cohen (1983) Alpha-1-antitrypsin deficiency. Clin. Chest Med., 4, 359-375.
31. [31] International Agency for Research on Cancer (1986) Tobacco smoking. IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Humans, International Agency for Research on Cancer, Lyon, France, Vol. 38.
32. [32] Izzotti, A., L. Scatolini, J. Lewtas, D. Walsh and S. De Flora (1995) Enhanced levels of DNA adducts in the liver of woodchucks infected with hepatitis virus. Chem.-Biol. Inter., 97, 273-285.
33. 32P-analysis of cigarette smoke induced DNA damage in human tissues and mouse skin. Cancer Res., 46, 5869-5877.
34. [34] Randerath, E., D. Mittal and K. Randerath (1988) Tissue distribution of covalent DNA damage in mice treated dermally with cigarette 'tar'. Preference for lung and heart DNA. Carcinogenesis, 9, 75-80.
35. [35] Gairola, C.G. and R.C. Gupta (1991) Cigarette smoke-induced DNA adducts in the respiratory and nonrespiratory tissues of rats. Environ. Mol. Mutagen., 17, 253-257.
36. [36] Vähäkangas, K., G. Trivers, M. Rowe and C.C. Harris (1985) Benzo[a]pyrene diolepoxide-DNA adducts detected by synchronous fluorescence spectrophotometry. Environ. Health Perspect., 62, 101-104.
37. [37] Izzotti, A., F. D'Agostini, M. Bagnasco, L. Scatolini, A. Rovida, R.M. Balansky, C.F. Cesarone and S. De Flora (1994) Chemoprevention of carcinogen-DNA adducts and chronic degenerative diseases. Cancer Res., 54 (Suppl.), 1994s-1998s.
38. [38] De Flora, S., R. Balansky, C. Bennicelli, A. Camoirano, F. D'Agostini, A. Izzotti and C.F. Cesarone (1995) Mechanisms of anticarcinogenesis: The example of N-acetylcysteine, in: C. Ioannides and D.F.V. Lewis (Eds.), Drugs, Diet and Disease, Vol. 1. Mechanistic Approaches to Cancer, Ellis Horwood, Hemel Hempstead, UK, pp. 151-203.
39. [39] van Schooten, F.J., M.J.X. Hillebrand, E. Scherer, L. den Engelse and E. Kriek (1991) Immunocytochemical visualization of DNA adducts in mouse tissues and human white blood cells following treatment with benzo[a]pyrene or its diol epoxide. A quantitative approach. Carcinogenesis, 12, 427-433.
40. 32P postlabeling assay of transplacental DNA damage induced by the environmental carcinogens safrole, 4-aminobiphenyl, and benzo[a]pyrene. Cancer Res., 46, 3046-3054.
41. [41] Sugimura, T. (1986) Studies on environmental chemical carcinogenesis in Japan. Science, 233, 312-318.
42. [42] Brittebo, E.B. (1994) Metabolic activation of the food mutagen Trp-P-1 in endothelial cells of heart and kidney in cytochrome P450-induced mice. Carcinogenesis, 15, 667-672.
43. [43] Davis, C.D., H.A.J. Schut and E.J. Snyderwine (1993) Enzymatic phase II activation of the N-hydroxylamino of IQ, MeIQx and PhIP by various organs of monkeys and rats. Carcinogenesis, 14, 2091-2096.
44. [44] Takayama, K., K. Yamashita, K. Wakabayashi, T. Sugimura and M. Nagao (1989) DNA modification by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in rats. Jpn. J. Cancer Res., 80, 1145-1148.
45. [45] Övervik, E., M. Ochiai, M. Hirose, T. Sugimura and M. Nagao (1991) The formation of heart DNA adducts in F344 rats following dietary administration of heterocyclic amines. Mutation Res., 256, 37-43.
46. [46] Yamashita, K., M. Adachi, S. Kato, H. Nakagama, M. Ochiai, K. Wakabayashi, S. Sato, M. Nagao and T. Sugimura (1990) DNA adducts formed by 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline in rat liver: dose-response on chronic administration. Jpn. J. Cancer Res., 81, 470-476.
47. [47] Adamson, R.H., E.G. Snyderwine, U.P. Thorgeirsson, H.A.J. Schut, R.J. Turesky, S.S. Thorgeirsson, S. Takayama and T. Sugimura (1991) Metabolic processing and carcinogenicity of heterocyclic amines in nonhuman primates, in: L. Ernster (Ed.), Xenobiotics and Cancer, Japan Sci. Soc. Press, Tokyo, pp. 289-301.
48. [48] Gaubatz, J.W. (1986) DNA damage during aging of mouse myocardium. J. Mol. Cell Cardiol., 18, 1317-1320.
49. [49] Gaubatz, J.W. (1989) Postlabeling analysis of indigenous aromatic DNA adducts in mouse myocardium during aging. Arch. Gerontol. Geriatr., 8, 47-54.
50. 32P-postlabeling assay. J. Natl. Cancer Inst., 81, 341-347.
51. [51] Lewtas, J., J. Mumford, R.B. Everson, B. Hulka, T. Wilcosky, W. Kozumbo, C. Thompson, M. George, L. Dobias, R. Sram, X. Li and J. Gallagher (1993) Comparison of DNA adducts from complex mixture exposures in various human tissues and experimental systems. Environ. Health Perspect., 99, 88-97.
52. [52] van Schooten, F.J., L.M. Maas, B.A. de Mol, J.C.S. Kleinjans and J.D. Durrer (1995) Enhanced DNA damage in heart tissue of cigarette smokers. 25th Annual Meeting of the European Environmental Mutagen Society, Noordwijkerhout, The Netherlands, Abstract, 4.37, p. 159.
53. [53] van Schooten, F.J., A. Hirvonen, L.M. Maas, B.A. de Mol, J.C.S. Kleinjans, D.A. Bell and J.D. Durrer (1996) Smoking induced DNA adducts in human right atrial tissue and glutathione S-transferase (GST) genotypes. Proc. Am. Assoc. Cancer Res., 37, Abstract, No. 720.
54. [54] Putnam, J.B., M.S. Sweeney, R. Colon, R.A. Lanza, O.H. Frazier and D.A. Cooley (1991) Primary cardiac sarcomas. Ann. Thorac. Surg., 51, 906-910.
55. [55] Tam, S.K., W. Gu, V., Mahdavi and B. Nadal-Ginard (1995) Cardiac myocyte terminal differentiation. Potential for cardiac regeneration. Ann. NY Acad. Sci., 752, 72-79.
56. [56] Thorgeirsson, U.P., A. Farb, R. Virmani and R.H. Adamson (1994) Cardiac damage induced by 2-amino-3-methylimlidazo[4,5-f]quinoline in non-human primates. Env. Health Perspect., 102, 194-199.
57. [57] Ferrari, R., C. Ceconi, S. Curello, A. Gargnoni, O. Alfieri, A. Pardini, P. Marzollo and O. Visioli (1991) Oxygen free radicals and myocardial damage: protective role of thiol containing agents. Am. J. Med., 91 (Suppl. 3C), 95-105.
58. [58] Ishikawa, T., T.P.M. Akerboom and H. Sies (1986) Role of key defense systems in target organ toxicity, in: G.M. Cohen (Ed.), Target Organ Toxicity, CRC Press, Boca Raton, FL, Vol. 1, pp. 129-143.
59. [59] Gvozdjàkovà, A., V. Bada, L. Sàny, J. Kucharskà, F. Kruty, P. Bozek, L. Trstansky and J. Gvozdjak (1984) Smoke cardiomyopathy: disturbance of oxidative processes in myocardial mitochondria. Cardiovascular Res., 18, 229-232.
60. [60] Hartz, A.J., A.J. Anderson, H.L. Brooks, J.C. Manley, G.D. Parent and J.J. Barboriak (1984) The association of smoking with cardiomyopathy. New Engl. J. Med., 311, 1201-1206.
61. [61] Lewtas, J., D. Walsh, J. Inmon, R. Curik and L. Dobiàs (1995) Distribution of DNA adducts in human cardiopulmonary autopsy tissues. Proc. 86th Ann. Meeting of the Am. Ass. for Cancer Res., Vol. 36, Abstract 652.
62. [62] Izzotti, A., S. De Flora, G.L. Petrilli, A. Gallagher, M. Rojas, K. Alexandrov, H. Bartsch and J. Lewtas (1995) Cancer biomarkers in human atherosclerotic lesions: detection of DNA adducts. Cancer Epidemiol. Biomarkers Prev., 4, 105-110.
63. [63] Izzotti, A., R.M. Balansky, L. Scatolini, A. Rovida and S. De Flora (1995) Inhibition by N-acetylcysteine of carcinogen-DNA adducts in the tracheal epithelium of rats exposed to cigarette smoke. Carcinogenesis, 16, 669-672.
64. [64] D'Agostini, F., G. Fronza, P. Campomenosi, A. Izzotti, G.L. Petrilli, A. Abbondandolo and S. De Flora (1995) Cancer biomarkers in human atherosclerotic lesions. II. No evidence of p53 involvement. Cancer Epidem. Biomarkers Prev., 4, 111-115.
65. [65] Bogliolo, M., G. Fronza, P. Campomenosi, P. Assereto, A. Izzotti, G.L. Petrilli, A. Abbondandolo and S. De Flora (1996) Cancer biomarkers in human atherosclerotic lesions. Lack of mutations in K-ras codons 12 and 13. Chem.-Biol. Inter., 102, 55-62.
66. 32P-postlabelling, Carcinogenesis, 16, 613-617.
67. [67] Chaudhary, A.K., M. Nokubo, G.R. Reddy, S.N. Yeola, J.D. Morrow, I.A. Blair and L.J. Marnett (1994) Detection of endogenous malondialdehyde-deoxyguanosine adducts in human liver, Science 265, 1580-1582.
68. 2-propanodeoxyguanosine adducts as common DNA lesions in rodents and humans, Proc. Natl. Acad. Sci. USA, 91, 7491-7495.
69. [69] Degan, P., S. Bonassi, M. De Caterina, L.G. Korkina, F. Scopacasa, A. Zatterale, R. Calzone and G. Pagano (1995) In vivo accumulation of 8-hydroxy-2′-deoxyguanosine in DNA correlates with release of reactive oxygen species in Fanconi's anaemia families. Carcinogenesis, 16, 735-741.
70. [70] Shimoda, R., M. Nagashima, M. Sakamoto, N. Yamaguchi, S. Hirohashi, J. Yokota and H. Kasai (1994) Increased formation of oxidative DNA damage, 8-hydroxydeoxyguanosine, in human livers with chronic hepatitis. Cancer Res., 54, 3171-3172.
71. [71] Bashir, S., G. Harris, M.A. Denman, D.R. Blake and P.G. Winyard. (1993) Oxidative DNA damage and cellular sensitivity to oxidative stress in human autoimmune diseases. Ann. Rheum. Dis., 52, 659-666.
72. [72] Lunec, J., K. Herbert, S. Blount, H.R. Griffiths and P. Emery (1994) 8-Hydroxydeoxy guanosine. A marker of oxidative DNA damage in systemic lupus erythematosus. FEBS Lett., 348, 131-138.
73. [73] Mecocci, P., U. MacGarvey and M.F. Beal (1994) Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease. Ann. Neurol., 36, 747-751.
74. [74] Gao, M., L.S. Levy, S.P. Faux, T.C. Aw, R.A. Braithwaite and S.S. Brown (1994) Use of molecular epidemiological techniques in a pilot study on workers exposed to chromium. Occup. Environ. Med., 51, 663-668.
75. [75] Inoue, T., Z. Mu, K. Sumikawa, K. Adachi and T. Okochi (1993) Effect of physical exercise on the content of 8-hydroxydeoxyguanosine in nuclear DNA prepared from human lymphocytes. Jpn. J. Cancer Res., 84, 720-725.
76. [76] Malins, D.C. and R. Haimanot (1991) Major alterations in the nucleotide structure of DNA in cancer of the female breast. Cancer Res., 51, 5430-5432.
77. [77] Speir, E., R. Modali, E-S. Huang, M.B. Leon, F. Shawl, T. Finkel and S.E. Epstein (1994) Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science, 265, 391-394.
78. [78] Penn, A., S.J. Garte, L. Warren, D. Nesta and B. Mindich (1986) Transforming gene in human atherosclerotic plaque DNA. Proc. Natl. Acad. Sci. USA, 83, 7951-7955.
79. [79] Indolfi, C., E.V. Avvedimento, A. Rapacciuolo, E. Di Lorenzo, G. Esposito, E. Stabile, A. Felicello, E. Mele, P. Giuliano, C. Condorelli and M. Chiariello (1995) Inhibition of cellular ras prevents smooth muscle cell proliferation after vascular injury in vivo. Nature Med., 1, 541-545.
80. 32P postlabeling. Cancer Res., 53, 1522-1528.
81. [81] Gallagher, J., U. Heinrich, M. George, L. Hendee, D.H. Phillips and J. Lewtas (1994) Formation of DNA adducts in rat lung following chronic inhalation of diesel emissions, 4carbon black and titanium dioxide particles. Carcinogenesis, 15, 1291-1299.
82. [82] Izzotti, A., A. Camoirano, F. D'Agostini, S. Sciacca, F. De Naro Papa, C.F. Cesarone and S. De Flora (1996) Biomarker alterations produced in rat lung by intratracheal instillations of air particulate extracts, and chemoprevention with oral N-acetylcysteine. Cancer Res., 56, 1533-1538.
83. 32P-adduct assay: comparative recoveries of structurally diverse DNA adducts in the various enhancement procedures. Carcinogenesis, 9, 1687-1693.
84. [84] De Flora, S., R. Balansky, L. Gasparini and A. Camoirano (1995) Bacterial mutagenicity of cigarette smoke and its interaction with ethanol. Mutagenesis, 10, 47-52.
85. [85] Li, D., M. Wang, J.G. Liehr and K. Randerath (1995) DNA adducts induced by lipids and lipid peroxidation products: possible relationship to I-compounds. Mutation Res., 344, 117-126.
86. [86] Izzotti, A., M. Bagnasco M., L. Scatolini, A. Rovida and S. De Flora (1993) Postmortem stability of benzo[a]pyrene diolepoxide-DNA adducts in rat organs. Carcinogenesis, 14, 2185-2187.
87. [87] Takayama, S., M. Sakamoto, Y. Hosoda and T. Sugimura (1987) Classification and angioproliferation in epicardium of mouse induced by mutagenic/carcinogenic heterocyclic amine. Proc. Jpn. Acad. Ser. B Phys. Biol. Sci., 63, 161-163.
88. [88] Wakabayashi, K. (1990) Animal studies suggesting involvement of mutagen/carcinogen exposure in atherosclerosis. Mutation Res., 239, 181-187.
89. [89] McManus, B.M., B. Toth and K.D. Patil (1987) Aortic rupture and aortic smooth muscle tumors in mice. Lab. Invest., 57, 78-85.
90. [90] Hansen, E. S. (1990) Shared risk factors for cancer and atherosclerosis: A review of the epidemiological evidence. Mutation Res., 239, 163-179.
91. [91] Duthie, K., K.W.J. Wahle and W.P.T. James (1989) Oxidants, antioxidants and cardiovascular disease. Nutrit. Res. Rev., 2, 51-62.
92. [92] Crawford, D.W. and D.H. Blankenhorn (1991) Arterial wall oxygenation, oxyradicals, and atherosclerosis. Atherosclerosis, 89, 97-108.
93. [93] Pettersson, F. and J. Swedenborg (1990) Atherosclerotic occlusive disease after radiation for pelvic malignancies. Acta Chir. Scand., 156, 367-371.
94. [94] Penn, A. and C. Snyder (1988) Arteriosclerotic plaque development is 'promoted' by polynuclear aromatic hydrocarbons. Carcinogenesis, 9, 2185-2189.
95. [95] Majesky, M.W., M.A. Reidy, E.P. Benditt and M.R. Juchau (1985) Focal smooth muscle proliferation in the aortic intima produced by an initiation-promotion sequence. Proc. Natl. Acad. Sci. USA, 82, 3450-3454.
96. [96] Zwijsen, R.M.L., L.H.J. de Haan, J.S. Oosting, H.L.M Pekelharing and J.H. Koeman (1990) Inhibition of intercellular communication in smooth muscle cells of humans and rats by low density lipoprotein, cigarette smoke condensate and TPA. Atherosclerosis, 85, 71-80.
97. [97] Ross, R.E. (1993) The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature, 362, 801-809.
98. [98] Smith, L.L. (1981) Distribution of autoxidation products, in: L.L. Smith (Ed.), Cholesterol Autoxidation, Plenum Press, New York, pp. 49-124.
99. [99] Peng, S.K., C.B. Taylor, P. Tham, N.T. Werthessen and B. Mikkelson (1989) Effect of autoxidation products from cholesterol on aortic smooth muscle cells. Arch. Pathol. Lab. Med., 102, 57-61.
100. [100] Imai, H., N.T. Werthessen, V. Subramanyam, P.W. LeQuesne, A.M. Soloway and M. Kanisawa (1980) Angiotoxicity of oxygenated sterols and possible precursors. Science, 207, 651-653.
101. [101] Sevanian, A. and A.R. Peterson (1986) The cytotoxicity and mutagenic properties of cholesterol oxidation products. Food Chem. Toxicol., 24, 1103-1110.
102. [102] Zwijsen, R.M.L. (1992) Cell-transforming potential of low-density lipoproteins. Carcinogenesis, 13, 1913-1915.
103. [103] Yoshida, Y., W. Sue, M. Okano, T. Oyama, T. Yamane and M. Mitsumata (1990) The effects of augmented hemodynamic forces on the progression and topography of atherosclerotic plaques. Ann. NY Acad. Sci., 598, 256-273.
104. [104] Ramos, K.S., E. Chacon and D. Acosta Jr. (1996) Toxic responses of the heart and vascular systems, in: C.D. Klaassen (Ed.), Casarett and Doull's Toxicology. The Basic Science of Poisons, McGraw-Hill, New York, pp. 487-527.
105. [105] Penn, A. (1990) Mutational events in the etiology of arteriosclerotic plaques. Mutation Res., 239, 149-162.
106. [106] Benditt, E.P. and J.M. Benditt (1973) Evidence for a monoclonal origin of human atherosclerotic plaques. Proc. Natl. Acad. Sci. USA, 70, 1753-1756.
107. [107] Gordon, D., M.A. Reidy, E.P. Benditt and S.M. Schwartz (1990) Cell proliferation in human coronary arteries. Proc. Natl. Acad. Sci. USA, 87, 4600-4604.
108. [108] Ross, R.E. (1986) The pathogenesis of atherosclerosis - An update. New Engl. J. Med., 314, 488-500.
109. [109] Grainger, D.J., H.L. Kirschenlohr, H.L., J.C. Metcaffe, P.L. Weissberg, D.P. Wade and R.M. Lawn (1993) Proliferation of human smooth muscle cells promoted by lipoprotein(a). Science, 260, 1655-1658.
110. [110] Bridges, B.A., D.E. Bowyer, E.S. Hansen, A. Penn and K. Wakabayashi. (Eds.) (1990) Report of ICPEMC Subcommitee 7/1. The Possible Involvement of Somatic Mutations in the Development of Atherosclerotic Plaques (special issue). Mutation Res., 239, 143-187.
111. [111] Thirman, M.J., J.H. Albrecht, M.A. Krueger, R.R. Erikson, D.L. Cherwitz, S.S. Park, H.V. Gelboin and J.L. Holtzman (1994) Induction of cytochrome CYPIA1 and formation of toxic metabolites of benzo[a]pyrene by rat aorta: a posible role in atherogenesis. Proc. Natl. Acad. Sci. USA, 91, 5397-5401.
112. [112] Hogg, S.I. and A. Cryer (1982) Aortic arylhydrocarbon hydroxylase activity in atherosclerosis-susceptible and atherosclerosis-resistant species. Comp. Biochem. Physiol., 73b, 669-671.
113. [113] Paigen, B., P.A. Holmes, A. Morrow and D. Mitchell (1986) Effect of 3-methylcholanthrene on atherosclerosis in two congenic strains of mice with different susceptibilities to methylcholanthrene-induced tumors. Cancer Res., 46, 3321-3324.
114. [114] Ou, X., T.J. Weber, R.S. Chapkin and K.S. Ramos (1995) Interference with protein kinase C-related signal transduction in vascular smooth muscle cells by benzo[a]pyrene. Arch. Biochem. Biophys., 760, 354-356.
115. 32P-postlabeling test for structurally diverse DNA adducts. Carcinogenesis, 7, 1543-1551.
116. 32P-postlabeling: Relationships to cancer and aging. Exp. Gerontol., 27, 533-549.
117. 32P-Postlabeling methods for DNA adduct detection: Overview and critical evaluation. Drug Metabol. Rev., 26, 67-85.
118. 32P-postlabeling assay and possible significance for spontaneous tumor induction and aging. Carcinogenesis, 7, 1615-1617.
119. [119] Randerath, K., D. Li and E. Randerath (1990) Age-related DNA modifications (I-compounds): Modulation by physiological and pathological processes. Mutation Res., 238, 245-253.
120. [120] Randerath, K., D. Li, B. Moorthy and E. Randerath (1993) I-Compounds - endogenous DNA markers of nutritional status, aging, tumor promotion and carcinogenesis, in: D.H. Phillips, M. Castegnaro and H. Bartsch, (Eds.), Postlabelling Methods for Detection of DNA Adducts, IARC Scientific Publications No. 124, International Agency for Research on Cancer, Lyon, pp. 157-165.
121. [121] Randerath, K., J. Chang and E. Randerath (1995) Age-dependent DNA modifications (I-compounds): Effects of carcinogenesis and oxidative stress, in: R.G. Cutler, L. Packer, J. Bertram and A. Mori (Eds.), Oxidative Stress and Aging, Birkhauser-Verlag, Basel, pp. 77-87.
122. [122] Randerath, E., G.-D. Zhou, R.W. Hart and K. Randerath (1995) Age-dependent indigenous covalent DNA modifications (I-compounds), in: R.W. Hart, D.A. Neumann and R.T. Robertson (Eds.), Dietary Restriction: Implications for the Design and Interpretation of Toxicity and Carcinogenicity Studies, ILSI Press, Washington, DC, pp. 229-244.
123. [123] Randerath, K., K.L. Putman, E. Randerath, G. Mason, M. Kelley and S. Safe (1988) Organ-specific effects of long term feeding of 2,3,7,8-tetrachlorodibenzo-p-dioxin and 1,2,3,7,8-pentachlorodibenzo-p-dioxin on I-compounds in hepatic and renal DNA of female Sprague-Dawley rats. Carcinogenesis, 9, 2285-2289.
124. [124] Randerath, K., G.-D. Zhou, R.W. Hart, A. Turturro and E. Randerath (1993) Biomarkers of aging: Correlation of DNA I-compound levels with median lifespan of calorically restricted and ad libitum fed rats and mice. Mutation Res., 295, 247-263.
125. [125] Randerath, E., W.P. Watson, G.-D. Zhou, J. Chang and K. Randerath (1995) Intensification and depletion of specific bulky renal DNA adducts (I-compounds) following exposure of male F344 rats to the renal carcinogen ferric nitrilotriacetate (Fe-NTA). Mutation Res., 341, 265-279.
126. 32P-postlabeling. Chem.-Biol. Interact., 84, 229-242.
127. 32P-postlabeling in DNA modified by oxidative damage in vitro. Comparison with rat lung I-compounds. Mutation Res., 250, 135-144.
128. [128] Randerath, K., E. Randerath, C.V. Smith and J. Chang (1996) Structural origins of bulky oxidative DNA adducts (Type II I-compounds) as deduced by oxidation of oligonucleotides of known sequence. Chem. Res. Toxicol., 9, 247-254.
129. 32P-postlabeling of DNA damage induced by an oxygen free-radical-generating system. Carcinogenesis, 13, 1127-1135.
130. [130] Marnett, L.J. (1994) DNA adducts of α,β-unsaturated aldehydes and dicarbonyl compounds, in: K. Hemminki, A. Dipple, D.E.G. Shuker, F. Kadlubar, D. Segerback and H. Bartsch (Eds.), DNA Adducts: Identification and Biological Significance, IARC Scientific Publications No. 125, International Agency for Research on Cancer, Lyon, pp. 151-163.
131. 2-propanodeoxyguanosine adducts and potential endogenous DNA lesions in rodent and human tissues. Cancer Res., 56, 452-456.
132. [132] Misra, M., R. Olinsky, M. Dizdaroglu and K.S. Kasprzak (1993) Enhancement by L-histidine of nickel(II)-induced DNA-protein crosslinking and oxidative DNA base damage in the rat kidney. Chem. Res. Toxicol., 6, 33-37.
133. [133] Zhuang, Z., X. Huang and M. Costa (1994) Protein oxidation and amino acid-DNA crosslinks by nickel compounds in intact cultured cells. Toxicol. Appl. Pharmacol., 126, 319-325.
134. [134] Nath, R.G., S.V. Vulimiri and K. Randerath (1992) Circadian rhythm of covalent modifications in liver DNA. Biochem. Biophys. Res. Commun., 189, 545-550.
135. [135] Randerath, K., E. Randerath and T.F. Danna (1990) Lack of I-compounds in DNA from a spectrum of Morris hepatomas. Carcinogenesis, 11, 1041-1044.
136. [136] Safe, S. (1990) Polychlorinated biphenyls (PCBs), dibenzo-p-dioxins (PCDDs), dibenzofurans (PCDFs), and related compounds: Environmental and mechanistic considerations which support the development of toxic equivalency factors (TEFs). Crit. Rev. Toxicol., 21, 51-88.
137. [137] Randerath, K., R.W. Hart, G.-D. Zhou, R. Reddy, T.F. Danna and E. Randerath (1993) Enhancement of age-related increases in DNA I-compound levels by calorie restriction: Comparison of male B-N and F-344 rats. Mutation Res., 295, 31-46.
138. [138] Gommers-Ampt, J.H. and P. Borst (1995) Hypermodified bases in DNA. FASEB J., 9, 1034-1042.
139. [139] Ames, B.N., L.S. Gold and W.C. Willett (1995) The causes and prevention of cancer. Proc. Natl. Acad. Sci. USA, 92, 5258-5265.
140. [140] Ames, B.N., Shigenaga, M.K. and Hagen T.M. (1995) Mitochondrial decay in aging. Biochem. Biophys. Acta, 1271, 165-170.
141. [141] Hamazaki, S., S. Okada, Y. Ebina, J.-L. Li and O. Midorikawa (1988) Effect of dietary vitamin E on ferric nitrilotriacetate-induced nephrotoxicity in rats. Toxicol. Appl. Pharmacol., 92, 500-506.
142. [142] Fraga, C., M.K. Shigenaga, J.W. Park, P. Degan and B.N. Ames (1990) Oxidative damage to DNA during aging: 8-hydroxy-2́-deoxyguanosine in rat organ DNA and urine. Proc. Natl. Acad. Sci. USA, 87, 4533-4537.
143. [143] Hirano, T., Y. Homma and H. Kasai (1995) Formation of 8-hydroxyguanine in DNA by aging and oxidative stress, in: R.G. Cutler, L. Packer, J. Bertram and A. Mori (Eds.), Oxidative Stress and Aging, Birkhauser Verlag, Basel, pp. 69-76.
144. [144] Shigenaga, M.K., C.J. Cimeno and B.N. Ames (1989) Urinary 8-hydroxy-2′-deoxyguanosine as biological marker of in vivo oxidative DNA damage. Proc. Natl. Acad. Sci. USA, 86, 9697-9701.
145. [145] Loeb, L.A. (1989) Endogenous carcinogenesis: molecular oncology into the twenty-first century. Presidential Address. Cancer Res., 49, 5489-5496.
146. [146] Lindahl, T. (1993) Instability and decay of the primary structure of DNA. Nature, 362, 709-715.
147. [147] Packer, L. (1995) Oxidative stress, antioxidants, aging and disease, in: R.G. Cutler, L. Packer, J. Bertram and A. Mori (Eds.), Oxidative Stress and Aging, Birkhauser Verlag, Basel, pp. 1-14.
148. [148] Sohal, R.S., B.S. Sohal and U.T. Brunk (1990) Relationship between antioxidant defenses and longevity in different mammalian species. Mech. Ageing Dev., 53, 217-227.
149. [149] Adelmann, R., R.L. Saul and B.N. Ames (1988) Oxidative damage to DNA: relation to species metabolic rate and life span. Proc. Natl. Acad. Sci. USA, 85, 2706-2708.
150. [150] Cutler, R.G. (1991) Antioxidants and aging. Am. J. Clin. Nutr., 53, 373S-379S.
151. [151] Orr, W.C. and R.S. Sohal (1994) Extension of life span by overexpression of superoxide dismutase and catalase in Drosophila melanogaster. Science, 263, 1128-1130.
152. [152] Casarett, G.W. (1964) Similarities and contrasts between radiation and pathology, in: B.L. Strehler (Ed.), Advances in Gerontology Research, Vol. 1, Clarendon Press, Oxford, pp. 109-163.
153. [153] Yu, C.-E., J. Oshima, Y.-H. Fu, E.M. Wijsman, F. Hisama, R. Alisch, S. Matthews, J. Nakura, T. Miki, S. Ouais, G.M. Martin, J. Mulligan and G.D. Schellenberg (1996) Positional cloning of Werner's syndrome gene. Science, 272, 258-262.
154. [154] Bronson, R.T. and R.D. Lipman (1991) Reduction in rate of occurrence of age-related lesions in dietary restricted laboratory mice. Growth Dev. Aging, 55, 169-184.
155. [155] Mecocci, P., U. MacGarvey, A.E. Kaufman, D. Koontz, J.M. Shoffner, D.C. Wallace and M.F. Beal (1993) Oxidative damage to mitochondrial DNA shows marked age-dependent increases in human brain. Annals Neurol., 34, 609-616.
156. [156] LeDoux, S.P., G.L. Wilson, E.J. Beecham, T. Stevnsner, K. Wassermann and V.A. Bohr (1992) Repair of mitochondrial DNA after various types of DNA damage in Chinese hamster ovary cells. Carcinogenesis, 13, 1967-1973.
157. [157] Gupta, K.P., K.L. van Golen, E. Randerath and K. Randerath (1990) Age-dependent covalent DNA alterations (I-compounds) in rat liver mitochondrial DNA. Mutation Res., 237, 17-27.
158. [158] Randerath, K., K.L. Putman, H.H. Osterburg, S.A. Johnson, D.G. Morgan and C.E. Finch (1993) Age-dependent increases of DNA adducts (I-compounds) in human and rat brain DNA. Mutation Res., 295, 11-18.
159. [159] Tritschler, J.-J., L. Packer and A. Medori (1994) Oxidative stress and mitochondrial dysfunction in neurodegeneration. Biochem. Mol. Biol. Int., 34, 169-181.
160. [160] Parker, W.D., C.M. Filley and J.K. Parks (1990) Cytochrome oxidase deficiency in Alzheimer's disease. Neurology, 40, 1302-1303.
161. [161] Harman, D. (1968) Free radical theory of aging: effect of free radical inhibitors on the mortality rate of male LAF1 mice. J. Gerontol., 23, 476-482.
162. [162] Fishbein, L. (Ed.) (1991) Biological Effects of Dietary Restriction. ILSI Monographs, Springer, New York.
163. [163] Hart, R.W., D.A. Neumann and R.T. Robertson (Eds.) (1995) Dietary Restriction. Implications for the Design and Interpretation of Toxicity and Carcinogenicity Studies. ILSI Press, Washington, DC.
164. [164] Weindruch, R. (1996) Caloric restriction and aging. Sci. Am., 1996, 46-52.
165. [165] Moorthy, B., P. Sriram and K. Randerath (1995) Effects of a single dose of the cytochrome P450 inducer, β-naphthoflavone, on hepatic and renal covalent DNA modifications (I-compounds). Toxicology, 104, 165-177.
166. [166] Feuers, R.J., D.A. Casciano, J.G. Shaddock, J.E.A. Leakey, P.H. Duffy, R.W. Hart, J.D. Hunter and L.E. Sheving (1991) Modifications in regulation of intermediary metabolism by caloric restriction in rodents, in: L. Fishbein (Ed.), Biological Effects of Dietary Restriction. ILSI Monographs, Springer, New York, pp. 108-206.
167. [167] Wolf, N.S. and W.R. Pendergrass (1995) In vivo cell replication rates are modulated by caloric intake, in: R.E. Hart, D.A. Neumann and R.T. Robertson (Eds.) Dietary Restriction. Implications for the Design and Interpretation of Toxicity and Carcinogenicity Studies, ILSI Press, Washington, DC, pp. 299-310.
168. [168] Ohshima, H. and H. Bartsch (1994) Chronic infections and inflammatory processes as cancer risk factors: possible role of nitric oxide in carcinogenesis. Mutation Res., 305, 253-264.
169. [169] Liu, R.H. and J.H. Hotchkiss (1995) Potential genotoxicity of chronically elevated nitric oxide: A review. Mutation Res., 339, 73-89.
170. [170] Marnett, L.J. (1996) Identification, detection, and genetic effects of DNA adducts of endogenous aldehydes (Abstract). Proc. Am. Assoc. Cancer Res., 37, 646.
171. [171] Marnett, L.J. and P.C. Burcham (1993) Endogenous DNA adducts: potential and paradox. Chem. Res. Toxicol. 6, 778-785.
172. [172] Bartsch, H., A. Barbin, M.-J. Marion, J. Nair and Y. Guichard (1994) Formation, detection and role in carcinogenesis of ethenobases in DNA, Drug Metab. Rev., 26, 349-371.
173. 4-ethenocytosine by lipid peroxidation products and nucleic acid bases, Chem. Res. Toxicol., 8, 278-283.
174. [174] Esterbauer, H., R.J. Schaur and H. Zollner (1991) Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radical Biol. Med., 11, 81-128.
175. [175] Hruszkewycz, A.M. (1992) Lipid peroxidation and mtDNA degeneration. A hypothesis. Mutation Res., 275, 243-248.
176. [176] Nair, J., H. Sone, M. Nagao, A. Barbin and H. Bartsch (1996) Copper-dependent formation of miscoding etheno-DNA adducts in the liver of Long Evans Cinnamon (LEC) rats developing hereditary hepatitis and hepatocellular carcinoma. Cancer Res., 56, 1267-1271.
177. [177] Yamamoto, F., H. Kasai, Y. Togashi, N. Takeichi, T. Hori and S. Nishimura (1993) Elevated level of 8-hydroxydeoxyguanosine in DNA of liver, kidneys, and brain of Long-Evans Cinnamon rats. Jpn. J. Cancer Res. 84, 508-511.
178. [178] Carmichael, P.L., A. Hewer, M.R. Osborne, A.J. Strain and D.H. Phillips (1995) Detection of bulky DNA lesions in the liver of patients with Wilson's disease and primary haemochromatosis. Mutation Res., 326, 235-243.
179. 4-ethenodeoxycytidine (edC) DNA adducts in liver of patients with Wilson's disease and primary hemochromatosis (Abstract). Proc. Am. Assoc. Cancer Res., 37, 117.
180. [180] Anderson, S., A.T. Bankier, B.G. Barrell, M.H.L. de Bruijn, A.R. Coulson, J. Drouin, I.C. Eperon, D.P. Nierlich, B.A. Roe, F. Sanger, P.H. Schreier, A.J.H. Smith, R. Staden and I.G. Young (1981) Sequence and organization of the human mitochondrial genome. Nature, 290, 457-465.
181. [181] Giles, R.E., H. Blanc, H.M. Cann and D.C. Wallace (1980) Maternal inheritance of human mitochondrial DNA. Proc. Natl. Acad. Sci. USA, 77, 6715-6719.
182. [182] Shay, J.W. and H. Werbin (1987) Are mitochondrial DNA mutations involved in the carcinogenic process? Mutation Res., 186, 149-160.
183. [183] Richter, C., J.-W. Park and B.N. Ames (1988) Normal oxidative damage to mitochondrial and nuclear DNA is extensive. Proc. Natl. Acad. Sci. USA, 85, 6465-6467.
184. [184] Kadenbach, B., C. Münsher, V. Frank, J. Müller-Höcker and J. Nopiwotzki (1995) Human aging is associated with stochastic somatic mutations of mitochondrial DNA. Mutation Res., 338, 161-172.
185. [185] Wallace, D.C. (1992) Mitochondrial genetics: a paradigm for aging and degenerative diseases. Science, 256, 628-632.
186. [186] Richter, C., V. Gogvadze, R. Laffranchi, R. Schlapbach, M. Schweizer, M. Suter, P. Walter and M. Yaffee (1995) Oxidants in mitochondria: from physiology to disease. Biochem. Biophys. Acta, 1271, 67-74.
187. [187] Thomas, R. and D. Roy (1995) Mitochondrial enzyme-catalyzed oxidation and reduction reactions of stilbene estrogen. Carcinogenesis, 16, 891-895.
188. [188] Wunderlich, V., M. Schutt, M. Bottger and A. Graffi (1970) Preferential alkylation of mitochondrial deoxyribonucleic acid by N-methyl-N-nitrosourea. Biochem. J., 118, 99-109.
189. [189] Wunderlich, V., I. Tetzlaff and A. Graffi (1971-1972) Studies on nitrosodimethylamine: preferential methylation of mitochondrial DNA in rats and hamsters. Chem.-Biol. Interact., 4, 81-89.
190. [190] Wilkinson, R.A., A. Hawks and A.E. Pegg (1975) Methylation of rat liver mitochondrial deoxyribonucleic acid by chemical carcinogens and associated alteration in physical properties. Chem.-Biol. Interact., 10, 157-168.
191. [191] Backer, J.M. and I.B. Weinstein (1980) Mitochondrial DNA is a major target for a dihydrodiol-epoxide derivative of benzo[a]pyrene. Science, 209, 297-299.
192. 1/2 cell cultures. Cancer Res., 42, 2764-2769.
193. [193] Allen, J.A. and M.M. Coombs (1980) Covalent binding of polycyclic aromatic compounds to mitochondrial and nuclear DNA. Nature, 287, 244-245.
194. [194] Niranjan, B.G., N.K. Bhat and N.G. Avadhani (1982) Preferential attack of mitochondrial DNA by aflatoxin B1 during hepatocarcinogenesis. Science, 215, 73-75.
195. [195] Shamsuddin, A.M., C.C. Harris and J. Hintzman (1987) Localization of aflatoxin B1-nucleic acid adducts in mitochondria and nuclei. Carcinogenesis, 8, 109-114.
196. [196] Olivero, O.A., C. Semino, A. Kassim, D.M. Lopez-Larraza and M.C. Poirier (1995) Preferential binding of cisplatin to mitochondrial DNA of Chinese hamster ovary cells. Mutation Res., 346, 221-230.
197. [197] Davis, C.D., H.A.J. Schut and E.J. Snyderwine (1994) Adduction of the heterocyclic amine food mutagens IQ and PhIP to mitochondrial and nuclear DNA in the liver of Fischer-344 rats. Carcinogenesis, 15, 641-645.
198. [198] Thomas, R. and D. Roy (1994) Mitochondrial DNA is a major target of attack by diethylstilbestrol metabolites in vivo. Proc. Am. Ass. Cancer Res., 35, 260.
199. [199] Périn-Roussel, O., F. Périn, N. Barat, M.-J. Plessis and F. Zajdela (1995) Interaction of 7H-dibenzo[c,g]carbazole and its organospecific derivatives with hepatic mitochondrial and nuclear DNA in the mouse. Environ. Mol. Mutagen., 25, 202-210.
200. [200] Balansky, R.M., L. Novikov, P. Giannoni, A. Izzotti and S. De Flora (1995) No effect of treatment with carcinogens on cytosine methylation of mitochondrial DNA isolated from rat organs by phenol-free alkaline extraction. Cancer Lett., 97, 17-23.
201. [201] Balansky, R., A. Izzotti, L. Scatolini, F. D'Agostini and S. De Flora (1996) Induction and chemoprevention of adducts to mitochondrial DNA. Cancer Res., 56, 1642-1647.
202. [202] Harman, D. (1972) The biological clock: the mitochondria?. J. Am. Geriatr. Soc., 20, 145-147.
203. [203] Miquel, J. and J.E. Fleming (1984) A two-step hypothesis on the mechanisms of in vitro cell aging: cell differentiation followed by intrinsic mitochondrial mutagenesis. Exp. Gerontol., 19, 31-36.
204. [204] Joenje, H. (Ed.) (1992) Molecular basis of aging: mitochondrial degeneration and oxidative damage (special issue). Mutation Res., 275, 1-417.
205. [205] Zeviani, M., E. Bonilla, D.C. DeVivo and S. DiMauro (1989) Mitochondrial disease. Neurol. Clin., 7, 123-156.
206. [206] Corral-Debrinski, M., T. Horton, M.T., Lott, J.M. Shiffner, M.F. Beal and D.C. Wallace (1992) Mitochondrial DNA deletions in human brain: regional variability and increase with advanced age. Nature Genet., 2, 324-329.
207. [207] Hamblet, N.S. and F.J. Castora (1995) Mitochondrial DNA deletion analysis: a comparison of PCR quantitative methods. Biochem. Biophys. Res. Commun., 207, 839-847.
208. [208] Bandy, B. and A.J. Davison (1990) Mitochondrial mutants may increase oxidative stress: implications for carcinogenesis and aging? Free Rad. Biol. Med., 8, 523-539.
209. [209] Hattori, K., T. Ogawa, T. Kondo, M. Mochizuki, M. Tanaka, S. Sugiyama, T. Ito, T. Satake and T. Ozawa (1991) Cardiomyopathy with mitochondrial DNA mutations. Am. Heart J., 122, 866-869.
210. [210] Wallace, D.C., J.M. Shoffner, I. Trounce, M.D. Brown, S.W. Ballinger, M. Corral-Debrinski, T. Horton, A.S. Jun and M.T. Lott (1995) Mitochondral DNA mutations in human degenerative diseases and aging. Biochem. Biophys. Acta, 1271, 141-151.
211. [211] Luft, R. (1995) The development of mitochondrial medicine. Biochem. Biophys. Acta, 1271, 1-6.
212. [212] De Flora, S., R. Balansky, L. Scatolini, C. Di Marco, L. Gasparini, M. Orlando and A. Izzotti (1996) Adducts to nuclear DNA and mitochondrial DNA as biomarkers in chemoprevention, in Principles of Chemoprevention, B.W. Stewart, D. McGregor and P. Kleihues (Eds.), IARC Sci. Publ. No. 139, International Agency for Research on Cancer, Lyon, France, pp. 291-301.
213. [213] Hermanson, B., G.S. Omenn, R.A. Kronmal, B.J. Gersh and participants in the Coronary Artery Surgery Study (1988) Beneficial six-year outcome of smoking cessation in older men and women with coronary artery disease. New Engl. J. Med., 319, 1365-1369.
214. [214] Brown, M.S. and J.L. Goldstein (1996) Heart attacks: Gone with the century? Science, 272, 629.
215. [215] Kelloff, G.J., C.W. Boone, V.E. Steele, J.A. Crowell, R. Lubet and C.C. Sigman (1994) Progress in cancer chemoprevention: perspectives on agent selection and short-term clinical intervention trials. Cancer Res., 54 (Suppl.), 2015s-2024s.
216. [216] De Flora, S., F. D'Agostini F., A. Izzotti and R. Balansky (1991) Prevention by N-acetylcysteine of benzo[a]pyrene clastogenicity and DNA adducts in rats. Mutation Res., 250, 87-93.
217. [217] Kelloff, G.J. and C.W. Boone (Eds.) (1994) Cancer chemopreventive agents: drug development status and future prospects. J. Cell Biochem., Suppl. 20, 1-303.
218. [218] De Flora, S., A. Camoirano, M. Bagnasco, C. Bennicelli, N. van Zandwijk, G. Wigbout, G.-s. Qian, Y.-r. Zhu and T.W. Kensler (1996) Smokers and urinary genotoxins. Implications for selection of cohorts and modulation of endpoints in chemoprevention trials. J. Cell Biochem., Suppl. 24, in press.
219. [219] Hemminki, K. (1993) Carcinogenesis, 14, 2007-2012.
220. [220] La, D.K. and J.A. Swenberg (1996) Mutation Res., 365, 129-146.
221. [221] van Zeeland, A.A. (1996) Mutation Res., 353, 123-150.